miR-126-5p suppresses HeLa and Ishikawa cell proliferation and migration via the RICTOR/AKT pathway
The findings reveal miR-126-5p as a critical regulator of uterine cancer progression and a promising therapeutic target. By addressing the limitations of current therapies, this study provides a foundation for the development of miRNA-based treatments, offering new hope for improving outcomes in uterine cancer patients.
Authors
- Xuan Zhang (ORCID: https://orcid.org/0000-0001-8775-1699)
- Wei Zhang (ORCID: https://orcid.org/0000-0003-2934-060X)
- Xianfang Song
- Yanjing Yang (ORCID: https://orcid.org/0009-0007-2113-3354)
- Yaqin Li (ORCID: https://orcid.org/0000-0003-2363-4834)
Institutions
- First Hospital of Shijiazhuang (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1007/s12672-025-02306-8
- Citations
- 1
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.94